John Schieszer, MA

Contributing Writer https://www.hematologyadvisor.com

John Schieszer is an award winning medical journalist who produces The Medical Minute podcasts. John received his BA in journalism from the University of Missouri-Columbia School of Journalism and his MA in english from the University of Missouri-St. Louis. In 1990, John was awarded the Case Western Reserve University School of Medicine’s Third Annual Fellowship for Journalists in Biomedical Research. In 1992, he completed a Medical Fellowship at the Marine Biological Laboratories in Woods Hole, Massachusetts.

All articles by John Schieszer, MA

Reviewing test results with a patient with cancer.

Leukemia

Tailored Approaches to Acute Myeloid Leukemia With Myelodysplasia-Related Changes

John Schieszer, MA

March 13, 2020

Patients with acute myeloid leukemia with myelodysplasia-related changes diagnosed on the basis of dysplasia reported improved overall and event-free survival.

Leukemia

Mutations Associated With Disseminated Intravascular Coagulation in Acute Leukemia

John Schieszer, MA

February 25, 2020

Researchers assessed the cytogenetic characteristics of coagulopathy in patients with molecularly distinct acute leukemias.

Complement C1s inhibition may prevent hemolysis in cold agglutinin disease.

Anemia

Thromboembolism Incidence With Splenectomy for Automimmune Hemolytic Anemia

John Schieszer, MA

February 24, 2020

Patients with autoimmune hemolytic anemia who underwent splenectomy experienced increased cumulative incidences of thromboembolism and sepsis.

Patients with lymphoma or myeloma completed were assessed prior to and 1 month after initiating chemotherapy for depressive symptoms.

General Hematology

Chemotherapy-Induced Nausea Prevention With Olanzapine Plus Standard Antiemetic Therapy

John Schieszer, MA

February 20, 2020

Higher proportions of patients receiving olanzapine reported only mild or no nausea compared with patients receiving placebo.

Lymphoma

Comparing Cost-Effectiveness of First-Line Treatment Approaches for Hodgkin Lymphoma

John Schieszer, MA

February 18, 2020

Of 5 treatment regimens assessed, a PET-adapted de-escalation treatment approach was found to be the most cost-effective in 87% of cases modelled.

Thrombotic Disorders

Risk Score to Prevent Bleeding With Vitamin K Antagonists for Venous Thromboembolism

John Schieszer, MA

February 11, 2020

Researchers developed a risk score to assess risk for vitamin K antagonist-associated bleeding events in patients with venous thromboembolism.

Myeloma

Considering Personalized Neoantigen Vaccine Approaches for Multiple Myeloma

John Schieszer, MA

January 22, 2020

Neoantigens may have the ability to provoke the immune system into recognizing and killing cancer cells in patients with multiple myeloma.

A geriatric doctor speaks to an elderly patient.

General Hematology

A Multipronged Approach to Geriatric Assessment Before Hematopoietic Cell Transplantation

John Schieszer, MA

December 20, 2019

Researchers implemented a multidisciplinary team clinic approach to assess candidacy of older adults for hematopoietic cell transplantation.

Myeloma

Identifying Cardiopulmonary Complications in Patients With Myeloma Treated With Carfilzomib

John Schieszer, MA

December 19, 2019

Cardiopulmonary adverse events with carfilozmib treatment included dyspnea, hypertension, peripheral edema, cough, pneumonia, and heart failure.

Lymphoma

Concomitant Diseases May Significantly Affect Outcomes in Patients With Mantle Cell Lymphoma

John Schieszer, MA

December 16, 2019

Severe comorbidities were found to be associated with increased all-cause and lymphoma-specific mortality compared with patients without comorbidities.

Next post in Lymphoma